Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Drugs of Abuse Screening Benefits from LoGiCal® Reference Materials

Published: Tuesday, October 30, 2012
Last Updated: Tuesday, October 30, 2012
Bookmark and Share
LoGiCal reference materials are very good quality and competitively priced.

Unilabs AB in Eskilstuna, Sweden, is taking advantage of LGC Standards’ LoGiCal reference materials to perform clinical analyses and screen for drugs of abuse, as chemist Elin Widing explained: “Unilabs is a privately owned clinical laboratory that analyses company healthcare and workplace samples, as well as samples from drug abuse centres. Samples are received from across Sweden and screened either qualitatively or semi-quantitatively using immunological assays, followed by quantitative LC-MSMS or GC-MS analysis for verification. Ready-to-use LoGiCal solutions are ideal for our purposes; it is so much simpler than weighing powders for inhouse preparation of reference materials.”

“We evaluated LoGiCal solutions of tetrahydrocannabinol (THC), zopiclone and alpha-hydroxyalprazolam, including deuterium-labelled alpha-hydroxyalprazolam as an internal standard for quantitative mass spectrometry analysis. Analyses were run in parallel with assays that were using our existing reference materials, and the results were comparable. LoGiCal reference materials are very good quality and competitively priced and, since the initial product evaluation, we have also ordered tramadol and its metabolites for our laboratory. In the future, as we purchase more reference materials, we intend to use LoGiCal solutions whenever they are available.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Developing Drug Resistance may be a Matter of Diversity for Tuberculosis
Researchers have probed the bacteria that causes tuberculosis, Mycobacterium tuberculosis, to learn more about how individual bacterial cells change and adapt while in the human body.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
Essential Component of Antiviral Defense Identified
Infectious disease researchers at the University of Georgia have identified a signaling protein critical for host defense against influenza infection.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Is Allergy the Price We Pay for Our Immunity to Parasites?
New findings help demonstrate the evolutionary basis for allergy.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
Mucus – the First Line of Defence
Researchers reveal the important role of mucus in building a good defence against invaders.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Gene-Edited Immune Cells Treat ‘Incurable’ Leukaemia
A new treatment that uses ‘molecular scissors’ to edit genes and create designer immune cells programmed to hunt out and kill drug resistant leukaemia has been used at Great Ormond Street Hospital (GOSH).

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos